

ValiRx, a biopharmaceutial company with a focus on the treatment of cancer, said while losses had widened in the first half it had made "excellent" ad...


ValiRx has been granted a patent for its lead therapeutic compound VAL201 for the treatment of breast, prostate, breast and ovarian cancer in Australi...


Shares in life science company ValiRx rose on Tuesday morning after the AIM-listed company announced that it would be presenting at the American Assoc...


Biotech firm ValiRx has appointed a Chief Operating Officer to assist in building and adding value to its portfolio of technologies and to coordinate ...


InterQuest has warned that trading during the summer, traditionally its strongest period, has been sluggish. As a result underlying earnings before in...